A Nationwide Survey and Multicenter Registry-Based Database of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy in Japan.

CADASIL NOTCH3 microbleeds migraine risk factors small vessel disease

Journal

Frontiers in aging neuroscience
ISSN: 1663-4365
Titre abrégé: Front Aging Neurosci
Pays: Switzerland
ID NLM: 101525824

Informations de publication

Date de publication:
2020
Historique:
received: 03 12 2019
accepted: 19 06 2020
entrez: 9 8 2020
pubmed: 9 8 2020
medline: 9 8 2020
Statut: epublish

Résumé

Clinical characteristics of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) include migraine, recurrent stroke, white matter lesions, and vascular dementia. CADASIL is one of the most common hereditary cerebral small vessel diseases. Clinical presentation of CADASIL varies and a racial gap may exist between the Asian and Caucasian populations. This is the first nationwide epidemiological survey which aimed to elucidate the clinical features of CADASIL in Japan. Moreover, the registration database of CADASIL was constructed. Subjects included CADASIL patients who visited the hospitals (totally 1,448 hospitals) certified by the Japanese Society of Neurology and/or Japan Stroke Society in 2016. This study consisted of a two-step survey; patients with CADASIL were identified genetically by the first questionnaire, and their clinical features were assessed by the second questionnaire. Selected 6 hospitals registered the data of all CADASIL patients using a Research Electronic Data Capture (REDCap) system for the second questionnaire. Based on the criteria, 88 patients (50 male and 38 female) with CADASIL were enrolled. The mean age of symptom onset was 49.5 years. Sixteen (18.2%) patients had an elderly onset (>60 years). Thirteen patients (13.6%) had history of migraine with aura and 33 patients (37.5%) had vascular risk factor(s). From among the 86 patients who were examined using magnetic resonance imaging, abnormal deep white matter lesions were detected in 85 patients (98.8%), WMLs extending to anterior temporal pole in 73 patients (84.9%), and cerebral microbleeds in 41 patients (47.7%). Anti-platelet therapy was received by 65 patients (73.9%). Thirty-eight patients (43.2%) underwent treatment with lomerizine hydrochloride. Thirty-four different mutations of This questionnaire-based study revealed clinical features and treatment status in Japanese CADASIL patient, although it may not be an exhaustive search. We have constructed the REDCap database for these CADASIL patients.

Identifiants

pubmed: 32765252
doi: 10.3389/fnagi.2020.00216
pmc: PMC7381163
doi:

Types de publication

Journal Article

Langues

eng

Pagination

216

Informations de copyright

Copyright © 2020 Shindo, Tabei, Taniguchi, Nozaki, Onodera, Ueda, Ando, Urabe, Kimura, Kitagawa, Hanyu, Hirano, Wakita, Fukuyama, Kagimura, Miyamoto, Takegami, Saito, Watanabe-Hosomi, Mizuta, Ihara, Mizuno and Tomimoto.

Références

J Stroke Cerebrovasc Dis. 2019 Jun;28(6):1431-1439
pubmed: 30956055
Eur J Neurol. 2014;21(1):65-71
pubmed: 23869710
Nature. 1996 Oct 24;383(6602):707-10
pubmed: 8878478
Stroke. 2010 Apr;41(4):630-4
pubmed: 20167921
Cephalalgia. 1997 Feb;17(1):15-22
pubmed: 9051330
J Neurol Neurosurg Psychiatry. 2005 May;76(5):739-41
pubmed: 15834040
J Neurol Sci. 2017 Oct 15;381:62-67
pubmed: 28991717
J Neurol Sci. 2015 Dec 15;359(1-2):347-50
pubmed: 26671140
Stroke. 2009 Jan;40(1):124-8
pubmed: 18948610
Ann N Y Acad Sci. 2002 Nov;977:273-8
pubmed: 12480761
J Stroke Cerebrovasc Dis. 2013 Jul;22(5):608-14
pubmed: 22133740
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Stroke. 2004 Jul;35(7):1603-8
pubmed: 15155961
J Neurol. 2015 Aug;262(8):1828-36
pubmed: 25980907
Lancet Neurol. 2009 Jul;8(7):643-53
pubmed: 19539236
Neurology. 2002 Oct 22;59(8):1134-8
pubmed: 12395806
PLoS One. 2018 Jan 25;13(1):e0190878
pubmed: 29370179
J Neurol. 2015 Jan;262(1):134-41
pubmed: 25344745
Neurology. 2006 May 23;66(10):1511-6
pubmed: 16717210
Circ J. 2017 Oct 25;81(11):1636-1646
pubmed: 28579600
AJR Am J Roentgenol. 1987 Aug;149(2):351-6
pubmed: 3496763
Cephalalgia. 1994 Apr;14(2):97-106
pubmed: 8062362
J Neurol Sci. 2003 Aug 15;212(1-2):79-84
pubmed: 12810003
Lancet Neurol. 2002 Nov;1(7):426-36
pubmed: 12849365
Cerebrovasc Dis. 2006;21(4):271-8
pubmed: 16446542
Stroke. 2012 Nov;43(11):2871-6
pubmed: 22996955
J Neurol Neurosurg Psychiatry. 2011 May;82(5):534-9
pubmed: 20935329
Cephalalgia. 1991 Jul;11(3):129-34
pubmed: 1889068
Brain. 2004 Sep;127(Pt 9):2031-8
pubmed: 15229130

Auteurs

Akihiro Shindo (A)

Department of Neurology, Mie University Graduate School of Medicine, Tsu, Japan.

Ken-Ichi Tabei (KI)

Department of Dementia Prevention and Therapeutics, Mie University Graduate School of Medicine, Tsu, Japan.

Akira Taniguchi (A)

Department of Neurology, Mie University Graduate School of Medicine, Tsu, Japan.

Hiroaki Nozaki (H)

Department of Neurology, Clinical Neuroscience Branch, Brain Research Institute, Niigata University, Niigata, Japan.

Osamu Onodera (O)

Department of Neurology, Clinical Neuroscience Branch, Brain Research Institute, Niigata University, Niigata, Japan.

Akihiko Ueda (A)

Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Yukio Ando (Y)

Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Department of Amyloidosis Research, Nagasaki International University, Nagasaki, Japan.

Takao Urabe (T)

Department of Neurology, Juntendo University Urayasu Hospital, Chiba, Japan.

Kazumi Kimura (K)

Department of Neurology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.

Kazuo Kitagawa (K)

Department of Neurology, Tokyo Women's Medical University, Tokyo, Japan.

Haruo Hanyu (H)

Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan.

Teruyuki Hirano (T)

Department of Stroke and Cerebrovascular Medicine, Kyorin University, Tokyo, Japan.

Hideaki Wakita (H)

Department of Internal Medicine, Nanakuri Memorial Hospital, Fujita Health University, Tsu, Japan.

Hidenao Fukuyama (H)

Center for the Promotion of Interdisciplinary Education and Research, Kyoto University, Kyoto, Japan.

Tatsuo Kagimura (T)

Translational Research Center for Medical Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan.

Yoshihiro Miyamoto (Y)

Center for Cerebral and Cardiovascular Disease Information, National Cerebral and Cardiovascular Center, Osaka, Japan.

Misa Takegami (M)

Department of Preventive Medicine and Epidemiologic Informatics, National Cerebral and Cardiovascular Center, Osaka, Japan.

Satoshi Saito (S)

Department of Neurology, National Cerebral and Cardiovascular Center, Suita, Japan.

Akiko Watanabe-Hosomi (A)

Department of Neurology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Ikuko Mizuta (I)

Department of Neurology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Masafumi Ihara (M)

Department of Neurology, National Cerebral and Cardiovascular Center, Suita, Japan.

Toshiki Mizuno (T)

Department of Neurology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Hidekazu Tomimoto (H)

Department of Neurology, Mie University Graduate School of Medicine, Tsu, Japan.

Classifications MeSH